Our Publications

2017

      1. Jovani M, Cao Y, Feskanich D, Drew DA, Hur C, Chan AT, et al. Aspirin Use is Associated With Lower Risk of Barrett’s Esophagus in Women. Clinical and Translational Gastroenterology. 2017;8(12):e131-. doi:10.1038/ctg.2017.57.
      2. Israelsen M, Krag A, Allegretti AS, Jovani M, Goldin AH, Winter RW, Gluud LL.  Terlipressin versus other vasoactive drugs for hepatorenal syndrome. Cochrane Database Syst Rev. 2017 Sep 27;9:CD011532. doi: 10.1002/14651858.CD011532.pub2. Review. PubMed PMID: 28953318.
      3. Allegretti AS, Israelsen M, Krag A, Jovani M, Goldin AH, Shulman AR, Winter RW, Gluud LL. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome. The Cochrane Library, 2017. DOI: 10.1002/14651858.CD005162.pub4
      4. Moris M, Raimondo M, Woodward TA, Skinner VJ, Arcidiacono PG, Petrone MC, De Angelis C, Manfrè S, Carrara S, Jovani M, Fusaroli P, Wallace MB. International Intraductal Papillary Mucinous Neoplasms Registry: Long-Term Results Based on the New Guidelines. Pancreas. 2017 Mar;46(3):306-310. doi: 10.1097/MPA.0000000000000750. PubMed PMID: 28099263.
      5. Nguyen LH, Lochhead P, Joshi AD, Cao Y, Ma W, Khalili H, Rimm EB, Rexrode KM, Chan AT. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication. Gastroenterology. 2017 Dec 18. pii: S0016-5085(17)36710-0. doi: 10.1053/j.gastro.2017.12.006.
      6. Simon TG, King LY, Chong DQ, Nguyen L, Ma Y, VoPham T, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Khalili H, Chung RT, Zhang X, Chan AT. Diabetes, Metabolic Comorbidities and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies. Hepatology. 2017 Nov 20. doi: 10.1002/hep.29660.
      7. Liu PH, Cao Y, Keeley BR, Tam I, Wu K, Strate LL, Giovannucci EL, Chan AT. Adherence to a Healthy Lifestyle is Associated With a Lower Risk of Diverticulitis among Men. Am J Gastroenterol. 2017 Dec;112(12):1868-1876. doi: 10.1038/ajg.2017.398.
      8. Song M, Wu K, Meyerhardt JA, Ogino S, Wang M, Fuchs CS, Giovannucci EL, Chan AT. Fiber Intake and Survival After Colorectal Cancer Diagnosis. JAMA Oncol. 2018 Jan 1;4(1):71-79. doi: 10.1001/jamaoncol.2017.3684.

      9. Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Lochhead P, Richter JM, Chan AT. Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study. Inflamm Bowel Dis. 2017 Nov;23(11):1898-1904. doi: 10.1097/MIB.0000000000001236.
      10. Lochhead P, Hagan K, Joshi AD, Khalili H, Nguyen LH, Grodstein F, Chan AT. Association Between Proton Pump Inhibitor Use and Cognitive Function in Women. Gastroenterology. 2017 Oct;153(4):971-979.e4. doi: 10.1053/j.gastro.2017.06.061.
      11. Khalili H, de Silva PS, Ananthakrishnan AN, Lochhead P, Joshi A, Garber JJ, Richter JR, Sauk J, Chan AT. Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2017 Jul;23(7):1088-1095. doi: 10.1097/MIB.0000000000001161.
      12. Lebwohl B, Cao Y, Zong G, Hu FB, Green PHR, Neugut AI, Rimm EB, Sampson L, Dougherty LW, Giovannucci E, Willett WC, Sun Q, Chan AT. Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. BMJ. 2017 May 2;357:j1892. doi: 10.1136/bmj.j1892.
      13. Cao Y, Wu K, Mehta R, Drew DA, Song M, Lochhead P, Nguyen LH, Izard J, Fuchs CS, Garrett WS, Huttenhower C, Ogino S, Giovannucci EL, Chan AT. Long-term use of antibiotics and risk of colorectal adenoma. Gut. 2017 Apr 4. pii: gutjnl-2016-313413. doi: 10.1136/gutjnl-2016-313413.
      14. Mehta RS, Song M, Nishihara R, Drew DA, Wu K, Qian ZR, Fung TT, Hamada T, Masugi Y, da Silva A, Shi Y, Li W, Gu M, Willett WC, Fuchs CS, Giovannucci EL, Ogino S, Chan AT. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes. Gastroenterology. 2017 Jun;152(8):1944-1953.e1. doi: 10.1053/j.gastro.2017.02.015.
      15. Strate LL, Keeley BR, Cao Y, Wu K, Giovannucci EL, Chan AT. Western Dietary Pattern Increases, and Prudent Dietary Pattern Decreases, Risk of Incident Diverticulitis in a Prospective Cohort Study. Gastroenterology. 2017 Apr;152(5):1023-1030.e2. doi: 10.1053/j.gastro.2016.12.038.
      16. Warner ET, Carapinha R, Weber GM, Hill EV, Reede JY. Gender Differences in Receipt of National Institutes of Health R01 Grants Among Junior Faculty at an Academic Medical Center: The Role of Connectivity, Rank, and Research Productivity. J Womens Health (Larchmt). 2017 Oct;26(10):1086-1093. doi: 10.1089/jwh.2016.6102.
      17. Drew DA, Nishihara R, Lochhead P, Kuchiba A, Qian ZR, Mima K, Nosho K, Wu K, Wang M, Giovannucci E, Fuchs CS, Chan AT, Ogino S. A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers. Am J Gastroenterol. 2017 Mar. doi: 10.1038/ajg.2016.589.
      18. Drew DA, Chin SM, Gilpin KK, Parziale M, Pond E, Schuck MM, Stewart K, Flagg M, Rawlings CA, Backman V, Carolan PJ, Chung DC, Colizzo FP 3rd, Freedman M, Gala M, Garber JJ, Huttenhower C, Kedrin D, Khalili H, Kwon DS, Markowitz SD, Milne GL, Nishioka NS, Richter JM, Roy HK, Staller K, Wang M, Chan AT. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. Trials. 2017 Feb 1;18(1):50. doi: 10.1186/s13063-016-1744-z.
      19. Spring L, Marshall M, Warner ET. Mammography decision-making: Trends, predictors and effects of provider communication in the Health Information National Trends Survey 2011-2014. Cancer. 2017 Feb 1. doi: 10.1002/cncr.30378
      20. Mehta RS, Nishihara R, Cao Y, Song M, Mima K, Qian ZR, Nowak JA, Kosumi K, Hamada T, Masugi Y, Bullman S, Drew DA, Kostic AD, Fung TT, Garrett WS, Huttenhower C, Wu K, Meyerhardt JA, Zhang X, Willett WC, Giovannucci EL, Fuchs CS, Chan AT, Ogino S. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium Nucleatum in Tumor Tissue. JAMA Oncol. 2017 Jan 26. doi: 10.1001/jamaoncol.2016.6374.
      21. Cao Y, Strate LL, Keeley BR, Wu K, Giovannucci EL, Chan AT. Meat consumption and risk of incident diverticulitis. Gut. 2017 Jan 9. doi: 10.1136/gutjnl-2016-313082
      22. Chu JN, Choi J, Tramontano A, Morse C, Forcione D, Nishioka NS, Abrams JA, Rubenstein JH, Kong CY, Inadomi JM, Hur C. Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis. Clin Gastroenterol Hepatol. 2017 Nov 24. pii: S1542-3565(17)31249-1. doi: 10.1016/j.cgh.2017.10.024.
      23. Kabrhel C, Ali A, Choi JG, Hur C. Systemic Thrombolysis, Catheter-Directed Thrombolysis, and Anticoagulation for Intermediate-risk Pulmonary Embolism: A Simulation Modeling Analysis. Acad Emerg Med. 2017 Oct;24(10):1235-1243. doi: 10.1111/acem.13242.
      24. Lubitz C, Ali A, Zhan T, Heberle C, White C, Ito Y, Miyauchi A, Gazelle GS, Kong CY, Hur C. The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population. PLoS One. 2017 May 8;12(5):e0177068. doi: 10.1371/journal.pone.0177068.
      25. Tramontano AC, Sheehan DF, Yeh JM, Kong CY, Dowling EC, Rubenstein JH, Abrams JA, Inadomi JM, Schrag D, Hur C. The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. Am J Gastroenterol. 2017 Aug;112(8):1256-1264. doi: 10.1038/ajg.2017.82.
      26. Heberle CR, Omidvari AH, Ali A, Kroep S, Kong CY, Inadomi JM, Rubenstein JH, Tramontano AC, Dowling EC, Hazelton WD, Luebeck EG, Lansdorp-Vogelaar I, Hur C. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device. Clin Gastroenterol Hepatol. 2017 Sep;15(9):1397-1404.e7. doi: 10.1016/j.cgh.2017.02.017.
      27. Kroep S, Heberle CR, Curtius K, Kong CY, Lansdorp-Vogelaar I, Ali A, Wolf WA, Shaheen NJ, Spechler SJ, Rubenstein JH, Nishioka NS, Meltzer SJ, Hazelton WD, van Ballegooijen M, Tramontano AC, Gazelle GS, Luebeck EG, Inadomi JM, Hur C. Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis. Clin Gastroenterol Hepatol. 2017 Sep;15(9):1471-1474. doi: 10.1016/j.cgh.2016.12.034.
      28. Klebanoff MJ, Corey KE, Chhatwal J, Kaplan LM, Chung RT, Hur C. Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. Hepatology. 2017 Apr;65(4):1156-1164. doi: 10.1002/hep.28958
      29. Borren NZ, Conway G, Garber JJ, Khalili H, Budree S, Mallick H, Yajnik V, Xavier RJ, Ananthakrishnan AN. Difference in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases. J Crohns Colitis. 2017 Nov 14. doi: 10.1093/ecco-jcc/jjx154.
      30. Gupta A, Agarwal R, Ananthakrishnan AN. "Weekend Effect" in Patients With Upper Gastrointestinal Hemorrhage: A Systematic Review and Meta-analysis. Am J Gastroenterol. 2018 Jan;113(1):13-21. doi: 10.1038/ajg.2017.430.
      31. Borren NZ, Conway G, Tan W, Andrews E, Garber JJ, Yajnik V, Ananthakrishnan AN. Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 Jul;23(7):1234-1239. doi: 10.1097/MIB.0000000000001133.
      32. Ananthakrishnan AN, Luo C, Yajnik V, Khalili H, Garber JJ, Stevens BW, Cleland T, Xavier RJ. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. Cell Host Microbe. 2017 May 10;21(5):603-610.e3. doi: 10.1016/j.chom.2017.04.010
      33. Borren NZ, Ghadermarzi S, Hutfless S, Ananthakrishnan AN. The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact. PLoS One. 2017 May 2;12(5):e0176797. doi: 10.1371/journal.pone.0176797.
      34. Burke KE, Boumitri C, Ananthakrishnan AN. Modifiable Environmental Factors in Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2017 May;19(5):21. doi: 10.1007/s11894-017-0562-0.
      35. Ananthakrishnan AN, Donaldson T, Lasch K, Yajnik V. Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities. Inflamm Bowel Dis. 2017 Jun;23(6):882-893. doi: 10.1097/MIB.0000000000001099.
      36. Velonias G, Conway G, Andrews E, Garber JJ, Khalili H, Yajnik V, Ananthakrishnan AN. Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2017 Feb;23(2):283-288. doi: 10.1097/MIB.0000000000001008.
      37. Staller K, Barshop K, Kuo B, Ananthakrishnan AN. Depression but Not Symptom Severity is Associated With Work and School Absenteeism in Refractory Chronic Constipation. J Clin Gastroenterol. 2017 Jan 5. doi: 10.1097/MCG.0000000000000782.
      38. Rice MS, Tworoger SS, Hankinson SE, Tamimi RM, Eliassen AH, Willett WC, Colditz G, Rosner B. Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model. Breast Cancer Res Treat. 2017 Nov;166(1):227-240. doi: 10.1007/s10549-017-4391-5.
      39. Rice MS, Rosner BA, Tamimi RM. Percent mammographic density prediction: development of a model in the nurses' health studies. Cancer Causes Control. 2017 Jul;28(7):677-684. doi: 10.1007/s10552-017-0898-7.
      40. Staller K, Barshop K, Ananthakrishnan AN, Kuo B. Number of retained radiopaque markers on a colonic transit study does not correlate with symptom severity or quality of life in chronic constipation. Neurogastroenterol Motil. 2017 Dec 18. doi: 10.1111/nmo.13269.
      41. Barshop K, Staller K. Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy. Ther Adv Chronic Dis. 2017 Nov;8(11):153-160. doi: 10.1177/2040622317714389.
      42. Koyfman S, Swartz K, Goldstein AM, Staller K. Laparoscopic-Assisted Percutaneous Endoscopic Cecostomy (LAPEC) in Children and Young Adults. J Gastrointest Surg. 2017 Apr;21(4):676-683. doi: 10.1007/s11605-016-3353-2
      43. Zakari M, Nee J, Hirsch W, Kuo B, Lembo A, Staller K. Gender differences in chronic constipation on anorectal motility. Neurogastroenterol Motil. 2017 Apr;29(4). doi: 10.1111/nmo.12980.

 

Return to top

2016 Publications

      1. Huang T, Tworoger SS, Hecht JL, Rice MS, Sood AK, Kubzansky LD, Poole EM. Association of ovarian tumor β2-adrenergic receptor status with ovarian cancer risk factors and survival. Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1587-1594
      2. Warner ET, Hu R, Collins LC, Beck AH, Schnitt S, Rosner BA, Eliassen AH, Michels KB, Willett WC, Tamimi RM. Height and body size in childhood, adolescence and young adulthood and breast cancer risk according to molecular subtype in the Nurses’ Health Studies. Cancer Prev Res (Phila). 2016 Sep;9(9):732-8. doi: 10.1158/1940-6207.CAPR-16-0085.
      3. Rice MS, Eliassen AH, Hankinson SE, Lenart EB, Willett WC, Tamimi RM. Breast Cancer Research in the Nurses' Health Studies: Exposures Across the Life Course. Am J Public Health. 2016 Sep;106(9):1592-8.
      4. Song M, Giovannucci E. Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States. JAMA Oncol. 2016 Sep 1;2(9):1154-61. doi: 10.1001/jamaoncol.2016.0843.
      5. Rice MS, Bertrand KA, VanderWeele TJ, Rosner BA, Liao X, Adami H, Tamimi RM. Mammographic density and breast cancer risk: a mediation analysis. Breast Cancer Res. 2016 Sep 21;18(1):94
      6. Eliassen AH, Warner ET, Rosner BA, Collins LC, Beck AH, Quintana LM, Tamimi RM, Hankinson SE. Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years. Cancer Res. 2016 Aug 16. pii: canres.0353.2016.
      7. Cao Y, Nishihara R, Wu K, Wang M, Ogino S, Willett WC, Spiegelman D, Fuchs, CS, Giovannucci EL, Chan AT. Population-wide impact of long-term use of aspirin and the risk of cancer. JAMA Oncol. 2016;2(6):762-769. doi:10.1001/jamaoncol.2015.6396
      8. Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC. Tamimi RM. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol. 2016 Aug 1. pii: JCO658013.
      9. Cao Y and Giovannucci EL. Alcohol as a risk factor for cancer. Seminars in Oncology Nursing. 2016 Aug;32(3):325-31.
      10. Cao Y and Giovannucci EL. Obesity and prostate cancer. Obesity and Cancer in Recent Results in Cancer Research, edited by Katharina Nimptsch and Tobias Pischon. Springer. 2016. 208:137-153.
      11. Cao Y*, Nishihara R*, Qian ZR*, Song M* et al. and Giovannucci EL*, Fuchs CS*, Chan AT*, Ogino S*. Regular aspirin use associates with lower risk of colorectal cancers with low numbers of tumor-infiltrating lymphocytes. Gastroenterology. 2016 Jul 27. doi: 10.1053/j.gastro.2016.07.030. (*co-first/senior author)
      12. Warner ET, Ballman KV, Strand C, Boughey JC, Buzdar AU, Carey LA, Sikov WM, Partridge AH. Impact of race, ethnicity and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (a151426). Breast Cancer Res Treat. 2016 Aug;159(1):109-18. doi: 10.1007/s10549-016-3918-5. Epub 2016 Jul 22.

Return to top

2015 Publications

      1. Gala MK, Austin T, Ogino S, Chan AT. TFF2-CXCR4 Axis is associated with BRAF V600E colon cancer. Cancer Prev Res. 2015 Apr 21. PMCID: PMC4490961.
      2. Song M, Nishihara R, Wu K, Qian ZR, Kim SA, Sukawa Y, Mima K, Inamura K, Masuda A, Yang J, Fuchs CS, Giovannucci EL, Ogino S, Chan AT. Marine n-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability. J Natl Cancer Inst. 2015 Mar 25; 107(4). PMCID: PMC4402363.
      3. Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, Chanock SJ, Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS, Giovannucci EL, Gong J, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Jiao S, Lindor NM, Lemire M, Le Marchand L, Newcomb PA, Ogino S, Pflugeisen BM, Potter JD, Qu C, Rosse SA, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Thibodeau SN, Thomas F, Thornquist M, Warnick GS, Zanke BW, Gauderman WJ, Peters U, Hsu L, Chan AT. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015 Mar 17. PMCID: PMC4382867
      4. Mehta RS, Chong DQ, Song M, Meyerhardt JA, Ng K, Nishihara R, Qian Z, Morikawa T, Wu K, Giovannucci EL, Fuchs CS, Ogino S, Chan AT. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality. Gastroenterology. 2015;149(3):614-622. doi:10.1053/j.gastro.2015.05.038.
      5. Maguire LH, Song M, Strate LL, Giovannucci EL, Chan AT. Association of geographic and seasonal variation with diverticulitis admissions. JAMA Surg. 2015 Jan; 150(1) 74-7.

Return to top

2014 Publications

      1. King LY, Johnson KB, Zheng H, Wei L, Gudewicz T, Hoshida Y, Corey KE, Ajayi T, Ufere N, Baumert TF, Chan AT, Tanabe KK, Fuchs BC, Chung RT. Host genetics predict clinical deterioration in HCV-related cirrhosis. PLoS One. 2014 Dec 12;9(12):e114747. doi: 10.1371/journal.pone.0114747. eCollection 2014. PMCID: PMC4264769.
      2. Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, Giannoukos G, Boylan MR, Ciulla D, Gevers D, Izard J, Garrett WS, Chan AT, Huttenhower C. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci USA. 2014 May 19. PMCID: PMC4050606.
      3. Bezawada N, Song M, Wu K, Mehta RS, Milne G, Fuchs CS, Giovannucci EL, Chan AT. Urinary prostaglandin metabolites (PGE-M) are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs. Cancer Prev Res. 2014 May 13. PMCID: PMC4085181.
      4. Fink S, Yamauchi, M, Nishihara R, Jung S, Kuchiba A, Wu K, Cho E, Giovannucci E, Fuchs C, Ogino S, Markowitz SD, Chan AT. Aspirin and the risk of colorectal cancer in relation to expression of 15-Hydroxyprostaglandin dehydrogenase expression. Sci Transl Med 2014 Apr 23; 6(233). PMCID:PMC4030641.
      5. Konijeti GG, Shrime MG, Ananthakrishnan AN, Chan AT. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc. 2014 Mar; 79(3): 455-65. PMCID: PMC4116277.
      6. Boylan, MR, Khalili H, Huang ES, Michaud DS, Izard J, Joshipura KJ, Chan AT. A prospective study of periodontal disease and risk of gastric and duodenal ulcer in male health professionals. Clin Transl Gastroenterol. 2014;5:e49. PMCID: PMC3940834.
      7. Mehta RS, Bezawada N, Wu K, Garcia-Albeniz X, Morikawa T, Fuchs CS, Ogino S, Giovannucci E, Chan AT. A prospective study of macrophage inhibitory cytokine-1 and risk of colorectal cancer. J Natl Cancer Inst. 2014 Feb 24. [Epub ahead of print]. PMID: 24565956. PMCID: PMC3982884.

Return to top

2013 Publications

      1. Nan H, Morikawa T, Suuriniemi M, Imamura Y, Werner L, Kuchiba A, Yamauchi M, Hunter DJ, Kraft P, Giovannucci EL, Fuchs CS, Ogino S, Freedman ML, Chan AT. Aspirin use, 8q24 single nucleotide polymorphism rs6983267 and colorectal cancer according to CTNNB1 alterations. J Natl Cancer Inst 2013 Dec 18; 105(24): 1852-61. PMCID: PMC3866156.
      2. Maguire LH, Song M, Strate LE, Giovannucci EL, Chan AT. Higher serum levels of vitamin D are associated with reduced risk of diverticulitis. Clin Gastro Hepatol 2013. PMCID: PMC3840074.
      3. Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses’ Health Study cohorts. BMJ. 2013 Nov 14. PMCID: PMC3935281.
      4. Hiraki LT, Qu C, Hutter CM, Baron J, Berndt SI, Bezieau S, Brenner H, Caan BJ, Casey G, Chang-Claude J, Chanock SJ, Conti DV, Duggan D, Fuchs CS, Gallinger S, Giovannucci EL, Harrison TA, Hayes RB, Hazra A, Henderson B, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Küry S, Le Marchand L, Lemire M, Ma J, Manson JE, Nan H, Newcomb PA, Ng K, Potter JD, Schoen RE, Schumacher F, Seminara D, Slattery ML, Wactawski-Wende J, White E, Wu K, Zanke BW, Kraft P, Peters U, Chan AT. Genetic predictors of circulating vitamin 25-Hydroxyvitamin D and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013. PMCID: PMC3818310.
      5. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, Inamura K, Kim SA, Kuchiba A, Yamauchi M, Imamura Y, Willett WC, Rosner BR, Fuchs CS, Giovannucci E, Ogino S, Chan AT. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013 Sept 19; 369(12):1095-105. PMCID: PMC3840160.
      6. Nishihara R, Lochhead P, Kuchiba A, Jung S, Yamauchi M, Liao X, Imamura Y, Qian ZR, Morikawa T, Wang M, Spiegelman D, Cho E, Giovannucci E, Fuchs CS, Chan AT*, Ogino S* (co-senior authors). Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA. 2013. 309(24): 2563-71. PMCID: PMC3743040
      7. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2013 Aug 1. PMCID: PMC3805714.
      8. , Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Willett WC, Richter JM, Chan AT. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut. 2013 Jul 4. PMCID: PMC3915038.
      9. Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KM, Giovannucci EL, Fuchs CS, Chan AT. Effect of vitamin D supplementation in blacks. Hypertension. 2013 Apr;61(4):779-85. PMCID: PMC3775458.

Return to top

2012 Publications

      1. Khalili H, Higuchi LM, Ananthakrishnan AN, Manson JE, Feskanich D, Richter JM, Fuchs CS, Chan AT. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology. 2012 Nov. 143(5); 33(32): 8026-33. PMCID:PMC3480540
      2. Liao X, Lochhead, P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian Z, Baba Y, Shima K;, Meyerhardt JA, Giovannucci E, Fuchs CS; Chan AT*, Ogino S* (co-senior authors) . Aspirin use, PIK3CA mutation, and colorectal cancer survival. N Engl J Med 2012 Oct 25;367(17):1596-606. PMCID: PMC3532946
      3. Phipps AI, Newcomb PA*, Garcia-Albeniz X, Hutter CM, White E, Fuchs CS, Hazra A, Ogino S, Nan H, Ma J, Campbell PT, Figueiredo JC, Peters U, Chan AT. Association between colorectal cancer susceptibility loci and survival time following diagnosis with colorectal cancer. Gastroenterology 2012 July. 143(1): 51-54. PMCID: PMC3579620.
      4. Khalili H, Huang ES, Ogino S, Fuchs CS, Chan AT. A prospective study of bisphosphonate use and risk of colorectal cancer. J Clin Oncology. 2012 May 29. PMCID: PMC3434982.
      5. Khalili H, Huang ES, Jacobson BC, Camargo CA, Feskanich D, Chan AT. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective study. BMJ 2012; 344: e372. PMCID: PMC3269660.
      6. Ananthakrishan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology 2012; 142(3): 482-9. PMCID: PMC3367959.
      7. Ananthakrishan AN, Higuchi LM, Huang ES, Khalili H, Richter JM, Fuchs CS, Chan AT. Aspirin, nonsteroidal anti-inflammatory drugs, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Internal Med 2012; 156 (5): 350-59. PMCID: PMC3369539.
      8. Khalili H, Higuchi L, Ananthakrishnan AN, Feskanich D, Richter JR, Fuchs CS, Chan AT. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut 2012 May 22. PMCID: PMC3465475.
      9. Khalili H, Huang ES, Ananthakrishnan AN, Higuchi L, Richter JM, Fuchs CS, Chan AT. Geographical variation and the risk of inflammatory bowel disease among U.S. women. Gut 2012 Jan 11. PMCID: PMC3418414.

Return to top

2011 Publications

      1. Chan AT, Ogino S, Giovannucci EL, Fuchs CS. Inflammatory markers are associated with risk of colorectal cancer and chemopreventative response to anti-inflammatory drugs. Gastroenterology. 2011. 140(3): 799-808. PMCID: PMC3049858.
      2. Huang ES, Strate LL, Ho WH, Lee SS, Chan AT. Long-term use of aspirin and the risk of gastrointestinal bleeding. Am J Med. 2011. 124(5): 426-33. PMCID: PMC3086018.
      3. Strate LL, Liu YL, Huang ES, Giovannucci EL, Chan AT. Use of aspirin and nonsteroidal anti-inflammatory drugs increases risk of diverticulitis and diverticular bleeding. Gastroenterology. 2011; 140: 1427-1433. PMCID: PMC3081980.
      4. Chan AT, Sima CS, Zauber AG, Ridker PM, Hawk ET, Bertagnolli MM. C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res. 2011. 4(8): 1-9. PMCID: PMC3151679.

Return to top

Publications prior to 2011

      1. Chan AT, Baba Y, Shima K, Nosho K, Chung DC, Hung KE, Mahmood U, Madden K, Poss K, Ranieri A, Shue D, Kucherlapati R, Fuchs CS, Ogino S. Cathepsin B expression and survival in colon cancer: Implications for molecular detection of neoplasia. Cancer Epidemiol Biomarkers Prev. 2010. 19 (11): 2777-85. PMCID: PMC2976771.
      2. Huang ES, Strate LL, Ho WH, Lee SS, Chan AT. A prospective study of aspirin use and the risk of gastrointestinal bleeding in men. PLOS One. 2010 Dec 29; 5(12): e15721. PMCID: PMC3012090
      3. Chan AT, Zauber AG, Hsu M, Breazna A, Hunter DJ, Rosenstein RB, Eagle CJ, Hawk ET, Bertagnolli MM. Cytochrome P450 2C9 Variants Influence Response to Celecoxib for Prevention of Colorectal Adenoma. Gastroenterology. 2009;136(7):2127-36. PMCID: PMC2693443.
      4. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649-58. PMCID: PMC2848289.
      5. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008;134(1):21-8. NIHMSID: NIHMS38884.
      6. Chan AT, Manson JE, Feskanich D, Stampfer MJ, Colditz GA, Fuchs CS. Long-term aspirin use and mortality in women. Arch Intern Med. 2007;167(6):562-72.
      7. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356(21):2131-42.
      8. Cho E, Willett WC, Colditz GA, Fuchs CS, Wu K, Chan AT, Zeisel SH, Giovannucci EL. Dietary choline and betaine and the risk of distal colorectal adenoma in women. J Natl Cancer Inst. 2007;99(16):1224-31. PMCID: PMC2441932.

Return to top

Click here for more publications on PubMed.

Back to Top